Clinical Trial Update: Study of Subretinal Implantation of Human Embryonic Stem Cell-Derived RPE Cells in Advanced Dry AMD [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for subretinal implantation of human embryonic stem cell-derived RPE cells in advanced dry AMD (Phase 1/Phase 2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Macular Degeneration
• Geographic Atrophy

Drugs mentioned

• Subretinal implantation of human embryonic stem cell-derived retinal pigment epithelium cells

Snippet

Sponsor: Regenerative Patch Technologies, LLC | Conditions: Dry Macular Degeneration, Geographic Atrophy | Phase 1, Phase 2 | Status: UNKNOWN